Related Experiment Video
Updated: Mar 7, 2026

Immunofluorescence Analysis of Endogenous and Exogenous Centromere-kinetochore Proteins
Published on: March 3, 2016
NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in
Hsin-Hsiung Chen1, Ping Fan1, Szu-Wei Chang1
1Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Abstract:
Both nuclear receptor interaction protein (NRIP) and DNA damage binding protein 2 (DDB2) belong to the Cullin 4 (CUL4)-DDB1 binding protein family and are androgen receptor (AR)-interacting proteins. Here, we investigated the expression patterns of the NRIP, DDB2 and AR proteins in human prostate cancer tissues and found that the expression levels of NRIP and AR were higher, but the DDB2 level was lower, in prostate cancer tissues than in non-neoplastic controls, suggesting NRIP as a candidate tumor promoter and DDB2 as a tumor suppressor in prostate cancer. Furthermore, both NRIP and DDB2 shared the same AR binding domain; they were competitors for the AR, but not for DDB1 binding, in the AR-DDB2-DDB1-CUL4A complex. Conclusively, NRIP stabilizes the AR protein by displacing DDB2 from the AR-DDB2 complex. Consistent with our hypothesis, a specific expression pattern with high levels of NRIP and AR, together with a low level of DDB2, was found more frequently in the human prostate cancer tissues with a cribriform pattern than in non-cribriform tumors, suggesting that disruption of the balance between NRIP and DDB2 may change AR protein homeostasis and contribute to pathogenesis in certain aggressive types of prostate cancer.
Insights
Nuclear receptor interaction protein (NRIP) promotes prostate cancer by stabilizing androgen receptor (AR), while DNA damage binding protein 2 (DDB2) acts as a tumor suppressor. Their imbalance impacts AR homeostasis and aggressive cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Nuclear receptor interaction protein (NRIP) and DNA damage binding protein 2 (DDB2) are part of the Cullin 4 (CUL4)-DDB1 binding protein family.
- Both NRIP and DDB2 interact with the androgen receptor (AR), a key factor in prostate cancer.
Purpose of the Study:
- To investigate the expression patterns of NRIP, DDB2, and AR in human prostate cancer tissues.
- To elucidate the competitive binding dynamics between NRIP and DDB2 for AR.
- To understand the role of NRIP and DDB2 in prostate cancer pathogenesis and AR protein stability.
Main Methods:
- Analysis of NRIP, DDB2, and AR protein expression levels in prostate cancer versus non-neoplastic tissues.
- Investigation of protein-protein interactions within the AR-DDB2-DDB1-CUL4A complex.
- Correlation of protein expression patterns with specific prostate cancer histological subtypes (cribriform vs. non-cribriform).
Main Results:
- NRIP and AR expression levels were elevated, while DDB2 levels were reduced in prostate cancer tissues compared to controls.
- NRIP and DDB2 compete for the same binding domain on AR, with NRIP displacing DDB2.
- High NRIP and AR, coupled with low DDB2, were more prevalent in aggressive cribriform prostate tumors.
Conclusions:
- NRIP acts as a potential tumor promoter by stabilizing AR protein through DDB2 displacement.
- DDB2 functions as a potential tumor suppressor in prostate cancer.
- The disrupted balance between NRIP and DDB2 may contribute to the pathogenesis of aggressive prostate cancer by altering AR protein homeostasis.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Anaphase Promoting Complex
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...